20-FABVXCIK 0001956827

Abivax S.A.

Name: SEC EDGAR filing 0001956827-25-000010
Creator: Abivax S.A.
License: https://www.usa.gov/government-works

Foreign annual (20-F) filed March 24, 2025.

Annual report filed by foreign private issuers listed on U.S. exchanges.

Read the filing on SEC.gov All documents in this filing

New to the 20-F? What it is and how to read one

Filing facts

Accession number: 0001956827-25-000010
Filer: Abivax S.A.
Ticker: ABVX
CIK: 0001956827
Form type: 20-F
Form description: Foreign annual
Filed at: March 24, 2025
Period of report: December 31, 2024
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 43.6 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Abivax S.A.

See all 22 filings from Abivax S.A. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1956827/000195682725000010/0001956827-25-000010-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Abivax S.A. (0001956827) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.